{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T13:23:37Z","timestamp":1780493017389,"version":"3.54.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T00:00:00Z","timestamp":1552262400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00066-019-01446-5","type":"journal-article","created":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T11:05:44Z","timestamp":1552302344000},"page":"544-557","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Favorable radiation field decrease in gastric marginal zone lymphoma","Erfolgreiche Strahlenfeldverkleinerung bei gastralem Marginalzonenlymphom"],"prefix":"10.1007","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4869-5986","authenticated-orcid":false,"given":"Gabriele","family":"Reinartz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina P.","family":"Pyra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00fcdiger","family":"Liersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"St\u00fcben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Micke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"Willborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens F.","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Probst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Fietkau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Jany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Schultze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"R\u00fcbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Hirt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Fischbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severin","family":"Daum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Pott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Tiemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Neubauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wilhelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Normann","family":"Willich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang E.","family":"Berdel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans T.","family":"Eich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,11]]},"reference":[{"key":"1446_CR1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1515\/9783110215144.175","volume-title":"Strahlenmedizin. Ein Leitfaden f\u00fcr Praktiker","author":"DM Aebersold","year":"2004","unstructured":"Aebersold DM, Vetterli D, Greiner RH (2004) Therapieplanung: 3D-konformierende Bestrahlung und intensit\u00e4tsmodulierte Strahlentherapie. In: Krukemeyer G, Wagner W (eds) Strahlenmedizin. Ein Leitfaden f\u00fcr Praktiker. De Gruyter, Berlin New York, pp 175\u2013189"},{"issue":"3","key":"1446_CR2","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.ijrobp.2004.10.025","volume":"62","author":"C Della Biancia","year":"2005","unstructured":"Della Biancia C, Hunt M, Furhang E, Wu E, Yahalom J (2005) Radiation treatment planning techniques for lymphoma of the stomach. Int J Radiat Oncol Biol Phys 62(3):745\u2013751. https:\/\/doi.org\/10.1016\/j.ijrobp.2004.10.025","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6\u20137","key":"1446_CR3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.canrad.2011.04.003","volume":"15","author":"V Gregoire","year":"2011","unstructured":"Gregoire V, Mackie TR (2011) State of the art on dose prescription, reporting and recording in Intensity-Modulated Radiation Therapy (ICRU report No. 83). Cancer 15(6\u20137):555\u2013559. https:\/\/doi.org\/10.1016\/j.canrad.2011.04.003","journal-title":"Cancer"},{"issue":"6","key":"1446_CR4","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1093\/jrr\/rru052","volume":"66","author":"K Inaba","year":"2014","unstructured":"Inaba K, Okamoto H, Wakita A, Nakamura S, Kobayashi K, Harada K et al (2014) Radiotherapy for gastric lymphoma: a planning study of 3D-conformal radiotherapy, the half-beam method, and intensity-modulated radiotherapy. J\u00a0Radiat Res 66(6):1141\u20131145. https:\/\/doi.org\/10.1093\/jrr\/rru052","journal-title":"J Radiat Res"},{"issue":"12","key":"1446_CR5","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s000660050047","volume":"175","author":"G Reinartz","year":"1999","unstructured":"Reinartz G, Kardels B, Koch P, Willich N (1999) Analysis of failures after whole abdominal irradiation in gastrointestinal lymphomas. Is prophylactic irradiation of inguinal lymph nodes required? German Multicenter Study Group on GI-NHL, University of Muenster. Strahlenther Onkol 175(12):601\u2013605","journal-title":"Strahlenther Onkol"},{"issue":"5","key":"1446_CR6","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s00066-016-0949-0","volume":"192","author":"G Reinartz","year":"2016","unstructured":"Reinartz G, Haverkamp U, Wullenkord R, Lehrich P, Kriz J, B\u00fcther F et al (2016) 4D-Listmode-PET-CT and 4D-CT for optimizing PTV margins in gastric lymphoma: determination of intra- and interfractional gastric motion. Strahlenther Onkol 192(5):322\u2013332. https:\/\/doi.org\/10.1007\/s00066-016-0949-0","journal-title":"Strahlenther Onkol"},{"key":"1446_CR7","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1200\/JCO.1998.16.5.1916","volume":"16","author":"NR Schechter","year":"1998","unstructured":"Schechter NR, Portlock CS, Yahalom J (1998) Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. J\u00a0Clin Oncol 16:1916\u20131921. https:\/\/doi.org\/10.1200\/JCO.1998.16.5.1916","journal-title":"J Clin Oncol"},{"issue":"1","key":"1446_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijrobp.2015.01.009","volume":"92","author":"J Yahalom","year":"2015","unstructured":"Yahalom J, Illidge T, Specht L, Hoppe RT, Li YX, Tsang R et\u00a0al (2015) Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 92(1):11\u201331. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.01.009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"16","key":"1446_CR9","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.1002\/cncr.25226","volume":"116","author":"JS Goda","year":"2010","unstructured":"Goda JS, Gospodarowicz M, Pintilie M, Wells W, Hodgson DC, Sun A et al (2010) Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy. Cancer 116(16):3815\u20133824. https:\/\/doi.org\/10.1002\/cncr.25226","journal-title":"Cancer"},{"issue":"6","key":"1446_CR10","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/annonc\/mdt343","volume":"24","author":"E Zucca","year":"2013","unstructured":"Zucca E, Copie-Bergman C, Ricardi U, Thieblemont C, Raderer M, Ladetto M (2013) Gastric marginal zone lymphoma of MALT type: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 24(6):144\u2013148. https:\/\/doi.org\/10.1093\/annonc\/mdt343","journal-title":"Ann Oncol"},{"issue":"18","key":"1446_CR11","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1200\/JCO.2001.19.18.3861","volume":"19","author":"P Koch","year":"2001","unstructured":"Koch P, del Valle F, Berdel WE, Willich NA, Reers B, Hiddemann W et al (2001) Primary gastrointestinal non-Hodgkin\u2019s lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German multicenter study GIT NHL 01\/92. J\u00a0Clin Oncol 19(18):3861\u20133873. https:\/\/doi.org\/10.1200\/JCO.2001.19.18.3861","journal-title":"J Clin Oncol"},{"key":"1446_CR12","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.1200\/JCO.2001.19.18.3874","volume":"19","author":"P Koch","year":"2001","unstructured":"Koch P, del Valle F, Berdel WE, Willich NA, Reers B, Hiddemann W et al (2001) Primary gastrointestinal non-Hodgkin\u2019s lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma. Results of the prospective German multicenter study GIT NHL 01\/92. J\u00a0Clin Oncol 19:3874\u20133883. https:\/\/doi.org\/10.1200\/JCO.2001.19.18.3874","journal-title":"J Clin Oncol"},{"issue":"28","key":"1446_CR13","doi-asserted-by":"publisher","first-page":"7050","DOI":"10.1200\/JCO.2005.04.031","volume":"23","author":"P Koch","year":"2005","unstructured":"Koch P, Probst A, Berdel WE, Willich NA, Reinartz G, Brockmann J et\u00a0al (2005) Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02\/96). J\u00a0Clin Oncol 23(28):7050\u20137059. https:\/\/doi.org\/10.1200\/JCO.2005.04.031","journal-title":"J Clin Oncol"},{"key":"1446_CR14","first-page":"52","volume-title":"Lymphome. Neue Erkenntnisse und Therapiestrategien","author":"K H\u00fcbel","year":"2005","unstructured":"H\u00fcbel K, Thomas RK, Diehl V (2005) Morbus Hodgkin. In: Hiddemann W, Dreyling M, Stein H (eds) Lymphome. Neue Erkenntnisse und Therapiestrategien, 1st\u00a0edn. Thieme, Stuttgart, pp\u00a052\u201369","edition":"1"},{"issue":"3","key":"1446_CR15","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","volume":"13","author":"A Trotti","year":"2003","unstructured":"Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V et\u00a0al (2003) CTCAE v3.0: development of a\u00a0comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13(3):176\u2013181. https:\/\/doi.org\/10.1016\/S1053-4296(03)00031-6","journal-title":"Semin Radiat Oncol"},{"issue":"5","key":"1446_CR16","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/0360-3016(95)00057-6","volume":"31","author":"P Rubin","year":"1995","unstructured":"Rubin P, Constine LS, Fajardo LF, Phillips TL, Wasserman TH (1995) RTOG Late Effects Working Group. Overview. Late effects of normal tissues (LENT) scoring system. Int J Radiat Oncol Biol Phys 31(5):1041\u20131042","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1446_CR17","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1023\/A:1008254617270","volume":"8","author":"B Coiffier","year":"1997","unstructured":"Coiffier B, Salles G (1997) Does surgery belong to medical history for gastric lymphomas? Ann Oncol 8:419\u2013421","journal-title":"Ann Oncol"},{"key":"1446_CR18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/01.sla.0000129356.81281.0c","volume":"240","author":"SS Yoon","year":"2004","unstructured":"Yoon SS, Coit DG, Portlock CS, Karpeh MS (2004) The diminishing role of surgery in the treatment of gastric lymphoma. Ann Surg 240:28\u201337","journal-title":"Ann Surg"},{"issue":"1","key":"1446_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ijrobp.2015.01.040","volume":"92","author":"S Teckie","year":"2015","unstructured":"Teckie S, Qi S, Lovie S, Navarrett S, Hsu M, Nov A et al (2015) Long-term outcomes and patterns of relapse of early-stage extranodal marginal zone lymphoma treated with radiation therapy with curative intent. Int J Radiat Oncol Biol Phys 92(1):130\u2013137. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.01.040","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1446_CR20","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1093\/annonc\/mds623","volume":"24","author":"A Wirth","year":"2013","unstructured":"Wirth A, Gospodarowicz M, Aleman BMP, Bressel M, Ng A, Chao M et al (2013) Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: a retrospective, multi-center, International Extranodal Lymphoma Group study. Ann Oncol 24:1344\u20131351. https:\/\/doi.org\/10.1093\/annonc\/mds623","journal-title":"Ann Oncol"},{"issue":"31","key":"1446_CR21","doi-asserted-by":"publisher","first-page":"e4250","DOI":"10.1097\/MD.0000000000004250","volume":"95","author":"YG Wang","year":"2016","unstructured":"Wang YG, Zhao LY, Liu CQ, Pan SC, Chen XL, Liu K et\u00a0al (2016) Clinical characteristics and prognostic factors of primary gastric lymphoma: a retrospective study with 165 cases. Medicine 95(31):e4250. https:\/\/doi.org\/10.1097\/MD.0000000000004250","journal-title":"Medicine"},{"issue":"36","key":"1446_CR22","doi-asserted-by":"publisher","first-page":"6062","DOI":"10.3748\/wjg.v19.i36.6062","volume":"19","author":"SW Kim","year":"2013","unstructured":"Kim SW, Lim DH, Ahn YC, Kim WS, Kim SJ, Ko YH et al (2013) Clinical outcomes of radiation therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma. World J Gastroenterol 19(36):6062\u20136068. https:\/\/doi.org\/10.3748\/wjg.v19.i36.6062","journal-title":"World J Gastroenterol"},{"key":"1446_CR23","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0360-3016(98)00083-2","volume":"41","author":"MH Maor","year":"1998","unstructured":"Maor MH, North LB, Cabanillas FF, Ames AL, Hess MA, Cox JD (1998) Outcomes of high-dose unilateral kidney irradiation in patients with gastric lymphoma. Int J Radiat Oncol Biol Phys 41:647\u2013650","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1446_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4143\/crt.2014.46.1.33","volume":"46","author":"TK Nam","year":"2014","unstructured":"Nam TK, Ahn JS, Choi YD, Jeong JU, Kim YH, Yoon MS et al (2014) The role of radiotherapy in the treatment of gastric mucosa-associated lymphoid tissue lymphoma. Cancer Res Treat 46(1):33\u201340. https:\/\/doi.org\/10.4143\/crt.2014.46.1.33","journal-title":"Cancer Res Treat"},{"issue":"5","key":"1446_CR25","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1093\/annonc\/mdx025","volume":"28","author":"S Teckie","year":"2017","unstructured":"Teckie S, Qi S, Chelius M, Lovie S, Hsu M, Nov A et al (2017) Long-term outcome of 487 patients with early-stage extra-nodal marginal zone lymphoma. Ann Oncol 28(5):1064\u20131069. https:\/\/doi.org\/10.1093\/annonc\/mdx025","journal-title":"Ann Oncol"},{"key":"1446_CR26","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1158\/1078-0432.CCR-04-2282","volume":"11","author":"M Raderer","year":"2005","unstructured":"Raderer M, Streubel B, Woehrer S, Puespoek A, Jaeger U, Formanek M et al (2005) High relapse rate in patients with MALT lymphoma warrants lifelong follow-up. Clin Cancer Res 11:3349\u20133352. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-2282","journal-title":"Clin Cancer Res"},{"key":"1446_CR27","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.radonc.2011.05.013","volume":"100","author":"L Lowry","year":"2011","unstructured":"Lowry L, Smith P, Qian W, Falk S, Benstead K, Illidge T et al (2011) Reduced dose radiotherapy for local control in Non-Hodgkin lymphoma: a randomised phase III trial. Radiother Oncol 100:86\u201392. https:\/\/doi.org\/10.1016\/j.radonc.2011.05.013","journal-title":"Radiother Oncol"},{"issue":"3","key":"1446_CR28","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.radonc.2008.02.012","volume":"87","author":"C Vrieling","year":"2008","unstructured":"Vrieling C, de Jong D, Boot H, de Boer JP, Wegmann F, Aleman BM (2008) Long-term results of stomach-conserving therapy in gastric MALT lymphoma. Radiother Oncol 87(3):405\u2013411. https:\/\/doi.org\/10.1016\/j.radonc.2008.02.012","journal-title":"Radiother Oncol"},{"key":"1446_CR29","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S1470-2045(14)70036-1","volume":"15","author":"P Hoskin","year":"2014","unstructured":"Hoskin P, Kirkwood A, Popova B, Smith P, Robinson M, Gallop-Evans E et al (2014) 4\u202fGy versus 24\u202fGy radiotherapy for patients with indolent lymphoma (FORT): a randomized phase 3 non-inferiority trial. Lancet Oncol 15:457\u2013463. https:\/\/doi.org\/10.1016\/S1470-2045(14)70036-1","journal-title":"Lancet Oncol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-019-01446-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-019-01446-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-019-01446-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T16:50:47Z","timestamp":1663087847000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-019-01446-5"}},"subtitle":["Experience of the German Study Group on Gastrointestinal Lymphoma (DSGL)","Erfahrungen der Deutschen Studiengruppe Gastrointestinale Lymphome (DSGL)"],"short-title":[],"issued":{"date-parts":[[2019,3,11]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["1446"],"URL":"https:\/\/doi.org\/10.1007\/s00066-019-01446-5","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,11]]},"assertion":[{"value":"22 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical guidelines"}},{"value":"G.\u00a0Reinartz, R.P.\u00a0Pyra, G.\u00a0Lenz, R.\u00a0Liersch, G.\u00a0St\u00fcben, O.\u00a0Micke, K.\u00a0Willborn, C.F.\u00a0Hess, A.\u00a0Probst, R.\u00a0Jany, J.\u00a0Schultze, C.\u00a0R\u00fcbe, C.\u00a0Hirt, W.\u00a0Fischbach, M.\u00a0Bentz, S.\u00a0Daum, C.\u00a0Pott, M.\u00a0Tiemann, P.\u00a0M\u00f6ller, A.\u00a0Neubauer, M.\u00a0Wilhelm, N.\u00a0Willich, W.E.\u00a0Berdel and H.T.\u00a0Eich declare that they have no competing interests. R.\u00a0Fietkau reports grants, personal fees and non-financial support from Merck Serono, personal fees and non-financial support from Fresenius Kabi, personal fees and non-financial support from Novocure, grants, personal fees and non-financial support from MSD, grants, personal fees and non-financial support from AstraZeneca, personal fees and non-financial support from Brainlab, personal fees and non-financial support from Sennewald GmbH, personal fees and non-financial support from Bristol-Myers Squibb, outside the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The trials were conducted in accordance with the Declaration of Helsinki on Ethical Principles for Medical Research after approval of the Ethical Board of the physicians\u2019 chamber of Westfalia-Lippe and the Westfalian Wilhelms-University of M\u00fcnster. The studies were reviewed by the local Ethical Committees (institutional review boards) of the involved trials sites.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}